Below are the financial statements of Cosmos Pharmaceutical, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in billions of JPY | 2024 | 2023 |
|---|---|---|
| Net sales | 964.99a | 827.7a |
| Cost of sales | -776.68a | -658.98a |
| Gross profit | 188.31a | 168.72a |
| Selling, general and administrative expenses | -156.8a | -138.59a |
| Operating income | 31.5a | 30.13a |
| Non-operating income | 3.64a | 3.68a |
| Non-operating expenses | -0.84a | -0.72a |
| Ordinary income | 34.3a | 33.09a |
| Extraordinary income | 0.63a | 0.05a |
| Extraordinary loss | -1.21a | -0.36a |
| Profit before income taxes | 33.72a | 32.77a |
| Income taxes | -9.27a | -8.98a |
| Net income | 24.45a | 23.8a |
| Net income attributable to owners of parent | 24.45a | 23.8a |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Cosmos Pharmaceutical’s data sources below and access millions more through our Disclosure Search.
Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.